istock-931018720-gwengoat
GwenGoat / iStockphoto.com
30 November 2018Big Pharma

EFPIA concerned over SPC waiver amendments

Proposed amendments to the EU’s supplementary protection certificate (SPC) manufacturing waiver risk “further disincentivising investment” in Europe, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
6 December 2018   The European Federation of Pharmaceutical Industries and Associations has sharply criticised an opinion on supplementary protection certificate proposals that was issued by a European Parliament committee.
Big Pharma
24 January 2019   The Legal Committee of the European Parliament has voted in favour of the proposed supplementary protection certificate waiver.
Generics
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.

More on this story

Big Pharma
6 December 2018   The European Federation of Pharmaceutical Industries and Associations has sharply criticised an opinion on supplementary protection certificate proposals that was issued by a European Parliament committee.
Big Pharma
24 January 2019   The Legal Committee of the European Parliament has voted in favour of the proposed supplementary protection certificate waiver.
Generics
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.

More on this story

Big Pharma
6 December 2018   The European Federation of Pharmaceutical Industries and Associations has sharply criticised an opinion on supplementary protection certificate proposals that was issued by a European Parliament committee.
Big Pharma
24 January 2019   The Legal Committee of the European Parliament has voted in favour of the proposed supplementary protection certificate waiver.
Generics
15 February 2019   The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.